QT Imaging touts prostate cancer screening study

By AuntMinnie.com staff writers

July 28, 2022 -- QT Imaging is highlighting the results of a study conducted by researchers from the U.S. National Cancer Institute that compared its QTscan technology to 7-tesla MRI for prostate cancer screening.

In a series of 10 patients, blinded readers interpreting prostate scans acquired with the company's QTscan system displayed equal or better sensitivity for detection of cancer compared with multiparametric 7-tesla MRI.

The company said that QT's technology, low-frequency transmitted ultrasound volography, demonstrated 85.7% sensitivity and 93.9% specificity, while multiparametric MRI had 65.3% sensitivity and 96.6% specificity. QT Imaging believes the results indicate that the technology has potential as a low-cost high-resolution modality for prostate cancer.

The study was performed in collaboration with the Center for Interventional Oncology at the National Cancer Institute and Johns Hopkins University.

Copyright © 2022 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking